This medication requires a valid prescription. Please refer to the ‘Prescription Guide’ for details.
Note: We can assist only if the medicine is unavailable in your country.”
Tavlesse (fostamatinib)
General Description:
Tavlesse (fostamatinib) is a prescription oral medication used for the treatment of adults with chronic immune thrombocytopenia (ITP). It is indicated for patients whose condition has not responded to other treatments.
Fostamatinib is a tyrosine kinase inhibitor that works by blocking spleen tyrosine kinase (SYK), reducing platelet destruction and increasing platelet counts in patients with chronic ITP.
Disease Indications:
Chronic Immune Thrombocytopenia (ITP)
Manufacturer:
Grifols
Usage:
Oral
Medicine Approved by:
• European Medicines Agency (EMA)
Package:
• 60 tablets × 100 mg
• 60 tablets × 150 mg
Shipping:
Room Temperature Shipping
Tavlesse is stable at room temperature and does not require refrigeration. It is shipped under standard shipping conditions (15°C to 25°C) to ensure the tablets remain effective and safe during transit.
Standard shipping provides a cost-effective way to deliver the medication while maintaining its stability and therapeutic efficacy.
How to Access Tavlesse (fostamatinib) in India in 4 Simple Steps with MitoGENE via the Named Patient Program (NPP)?
If Tavlesse (fostamatinib) is not yet approved or commercially available in India, MitoGENE can assist patients and healthcare providers in legally obtaining it through the Named Patient Program (NPP).
Here’s how the process works:
